B. Riley Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $652K | Buy |
+9,451
| New | +$652K | 0.03% | 435 |
|
|
2024
Q4 | $3.16M | Sell |
36,734
-2,748
| -7% | -$236K | 0.1% | 198 |
|
|
2024
Q3 | $4.62M | Sell |
39,482
-20,024
| -34% | -$2.34M | 0.13% | 173 |
|
|
2024
Q2 | $8.49M | Buy |
59,506
+5,510
| +10% | +$786K | 0.22% | 94 |
|
|
2024
Q1 | $4.91M | Buy |
53,996
+3,219
| +6% | +$293K | 0.13% | 159 |
|
|
2023
Q4 | $5.25M | Sell |
50,777
-3,219
| -6% | -$333K | 0.14% | 168 |
|
|
2023
Q3 | $4.91M | Buy |
53,996
+9,832
| +22% | +$894K | 0.13% | 159 |
|
|
2023
Q2 | $3.57M | Buy |
44,164
+2,990
| +7% | +$242K | 0.08% | 240 |
|
|
2023
Q1 | $3.3M | Sell |
41,174
-2,640
| -6% | -$211K | 0.09% | 228 |
|
|
2022
Q4 | $2.96M | Sell |
43,814
-4,780
| -10% | -$323K | 0.08% | 247 |
|
|
2022
Q3 | $2.42M | Buy |
48,594
+8,914
| +22% | +$444K | 0.07% | 267 |
|
|
2022
Q2 | $2.21M | Buy |
39,680
+2,668
| +7% | +$149K | 0.09% | 220 |
|
|
2022
Q1 | $2.06M | Buy |
37,012
+26
| +0.1% | +$1.45K | 0.07% | 296 |
|
|
2021
Q4 | $2.07M | Buy |
36,986
+1,236
| +3% | +$69.2K | 0.06% | 340 |
|
|
2021
Q3 | $1.7M | Buy |
35,750
+286
| +0.8% | +$13.6K | 0.05% | 379 |
|
|
2021
Q2 | $1.47M | Sell |
35,464
-256
| -0.7% | -$10.6K | 0.05% | 407 |
|
|
2021
Q1 | $1.2M | Buy |
+35,720
| New | +$1.2M | 0.04% | 432 |
|
|
2015
Q1 | – | Sell |
-1,832
| Closed | -$39 | – | 1499 |
|
|
2014
Q4 | $39 | Buy |
+1,832
| New | +$39 | ﹤0.01% | 2222 |
|
|
2014
Q3 | – | Sell |
-2,092
| Closed | -$48.3K | – | 1464 |
|
|
2014
Q2 | $48.3K | Buy |
+2,092
| New | +$48.3K | 0.01% | 1046 |
|